Wells Fargo’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Wells Fargo’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-279,495	Closed	-$4.08M	–	7805
2023 Q1	$4.08M	Sell	279,495 -13,903	-5%	-$196K	﹤0.01%	2288
2022 Q4	$2.14M	Buy	293,398 +63,204	+27%	+$446K	﹤0.01%	2734
2022 Q3	$1.59M	Buy	230,194 +196,569	+585%	+$1.47M	﹤0.01%	2901
2022 Q2	$235K	Hold	33,625	–	–	﹤0.01%	4186
2022 Q1	$278K	Hold	33,625	–	–	﹤0.01%	4793
2021 Q4	$363K	Sell	33,625 -604	-2%	-$6.52K	﹤0.01%	4920
2021 Q3	$412K	Buy	+34,229	New	+$386K	﹤0.01%	4769

Wells Fargo's AMYT Position: Q2 2023 in Review

Wells Fargo sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 279,495 shares — an estimated $4.08M sold.

Wells Fargo first reported a position in AMYT in Q3 2021 and held it in 7 quarters. The position peaked at $4.08M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Wells Fargo reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Wells Fargo sold 279,495 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $4.08M.
Wells Fargo first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
Wells Fargo's Amryt Pharma plc American Depositary Shares position peaked at $4.08M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.